Supporting Innovation and Entrepreneurship for more than 60 years

Welcome to Safeguard Scientifics' Blog, where we share Perspective, Strategy and Insight.

Archive: IPO

Corporate

Safeguard CEO featured on TheStreet.com

Last week, Safeguard Scientifics’ President and CEO Peter J. Boni sat down with Gregg Greenberg of TheStreet.com to discuss the emergence of IPO candidates from the doldrums of last year’s lackluster activity. Check out this video that highlights Peter’s insight as to why the tide might be turning in the IPO arena. In particular, Peter cites areas of increased activity:…

Read more

Life Sciences

IPOs: A Financing Event

On the heels of continued IPO activity, there has been a flurry of media coverage — both positive and negative — regarding the companies that have gone public and the overall macroeconomic environment. Most recently, there has been a lot of coverage of one of Safeguard’s partner companies, NuPathe, which is developing a single-use transdermal sumatriptan patch for the treatment…

Read more

Macro Economy

Exit Environment and Valuations

According to new research published in this month’s Journal of Business Venturing, privately held businesses that start the initial public offering (IPO) process at the same time that they put themselves on the block command a premium price — as much as 26 percent higher — over those that solely seek a single buyer. That’s according to an article from…

Read more